Successful treatment of systemic EBV-positive T-cell lymphoma of childhood using the ruxolitinib combined with L-DEP regimen chemotherapy followed by haploidentical allogeneic hematopoietic stem cell transplantation
Source: Annals of Hematology - Category: Hematology Source Type: research
More News: Chemotherapy | Hematology | Lymphoma | Stem Cell Therapy | Stem Cells | T-cell Lymphoma | Transplants